Muti P - Search Results

1

VDR primary targets by genome-wide transcriptional profiling.

Goeman F, De Nicola F, D'Onorio De Meo P, Pallocca M, Elmi B, Castrignanò T, Pesole G, Strano S, Blandino G, Fanciulli M, Muti P. Goeman F, et al. Among authors: muti p. J Steroid Biochem Mol Biol. 2014 Sep;143:348-56. doi: 10.1016/j.jsbmb.2014.03.007. Epub 2014 Apr 13. J Steroid Biochem Mol Biol. 2014. PMID: 24726990 Free article.

2

The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis.

Fontemaggi G, Dell'Orso S, Trisciuoglio D, Shay T, Melucci E, Fazi F, Terrenato I, Mottolese M, Muti P, Domany E, Del Bufalo D, Strano S, Blandino G. Fontemaggi G, et al. Among authors: muti p. Nat Struct Mol Biol. 2009 Oct;16(10):1086-93. doi: 10.1038/nsmb.1669. Epub 2009 Sep 27. Nat Struct Mol Biol. 2009. PMID: 19783986

3

Omics underpins novel clues on VDR chemoprevention target in breast cancer.

Muti P, Benassi B, Falvo E, Santoro R, Galanti S, Citro G, Carrubba G, Blandino G, Strano S. Muti P, et al. OMICS. 2011 Jun;15(6):337-46. doi: 10.1089/omi.2010.0086. Epub 2011 Feb 24. OMICS. 2011. PMID: 21348760 Review.

4

Cdx2 polymorphism affects the activities of vitamin D receptor in human breast cancer cell lines and human breast carcinomas.

Pulito C, Terrenato I, Di Benedetto A, Korita E, Goeman F, Sacconi A, Biagioni F, Blandino G, Strano S, Muti P, Mottolese M, Falvo E. Pulito C, et al. Among authors: muti p. PLoS One. 2015 Apr 7;10(4):e0124894. doi: 10.1371/journal.pone.0124894. eCollection 2015. PLoS One. 2015. PMID: 25849303 Free PMC article.

5

What biomarkers (if any) for precise medicine?

Strano S, Muti P, Blandino G. Strano S, et al. Among authors: muti p. Aging (Albany NY). 2015 Aug;7(8):533-4. doi: 10.18632/aging.100798. Aging (Albany NY). 2015. PMID: 26319119 Free PMC article. No abstract available.

6

Use of Buffy Coat miRNA Profiling for Breast Cancer Prediction in Healthy Women.

Donzelli S, Blandino G, Muti P. Donzelli S, et al. Among authors: muti p. Methods Mol Biol. 2016;1379:13-9. doi: 10.1007/978-1-4939-3191-0_2. Methods Mol Biol. 2016. PMID: 26608286

7

Multitargeting activity of miR-24 inhibits long-term melatonin anticancer effects.

Mori F, Ferraiuolo M, Santoro R, Sacconi A, Goeman F, Pallocca M, Pulito C, Korita E, Fanciulli M, Muti P, Blandino G, Strano S. Mori F, et al. Among authors: muti p. Oncotarget. 2016 Apr 12;7(15):20532-48. doi: 10.18632/oncotarget.7978. Oncotarget. 2016. PMID: 26967561 Free PMC article.

8

Long Non-coding MIR205HG Depletes Hsa-miR-590-3p Leading to Unrestrained Proliferation in Head and Neck Squamous Cell Carcinoma.

Di Agostino S, Valenti F, Sacconi A, Fontemaggi G, Pallocca M, Pulito C, Ganci F, Muti P, Strano S, Blandino G. Di Agostino S, et al. Among authors: muti p. Theranostics. 2018 Feb 12;8(7):1850-1868. doi: 10.7150/thno.22167. eCollection 2018. Theranostics. 2018. PMID: 29556360 Free PMC article.

9

Melatonin and Hippo Pathway: Is There Existing Cross-Talk?

Lo Sardo F, Muti P, Blandino G, Strano S. Lo Sardo F, et al. Among authors: muti p. Int J Mol Sci. 2017 Sep 6;18(9):1913. doi: 10.3390/ijms18091913. Int J Mol Sci. 2017. PMID: 28878191 Free PMC article.

10

MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function.

Donzelli S, Fontemaggi G, Fazi F, Di Agostino S, Padula F, Biagioni F, Muti P, Strano S, Blandino G. Donzelli S, et al. Among authors: muti p. Cell Death Differ. 2012 Jun;19(6):1038-48. doi: 10.1038/cdd.2011.190. Epub 2011 Dec 23. Cell Death Differ. 2012. PMID: 22193543 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

294 results

Search Page